Cipla receives U.S. FDA approval for generic of asthma, COPD drug
Food and Drug Administration headquarters in White Oak, Maryland | Photo Credit: Reuters Cipla has received approval from the U.S. Food and Drug Administration (U.S. FDA) for its abbreviated new drug application (ANDA) for generic Advair Diskus (fluticasone propionate and salmeterol inhalation powder) in three strengths — 100/50 mcg, 250/50 mcg, and 500/50 mcg ….
Read More “Cipla receives U.S. FDA approval for generic of asthma, COPD drug” »